Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...